Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Tyra genes and uses thereof

a technology of tocopherol and genes, applied in the field of plant genetics and biochemistry, can solve the problems of relatively high cost of supplements and difficult to achieve the recommended daily intake of 15-30 mg of vitamin e from the average american diet, and achieve the effect of increasing the tocopherol level

Inactive Publication Date: 2008-04-10
MONSANTO TECH LLC
View PDF27 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The recommended daily dietary intake of 15-30 mg of vitamin E is quite difficult to achieve from the average American diet.
Furthermore, supplements tend to be relatively expensive, and the general population is disinclined to take vitamin supplements on a regular basis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tyra genes and uses thereof
  • Tyra genes and uses thereof
  • Tyra genes and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

Cloning of tyrA from Erwinia herbicola

[0331] Vectors pJX1, pJX181, and pJX184 are obtained (Zhao and Jensen of Molecular Evolution 36(2):107-20 (1993)). The tyrA gene is amplified by PCR using primers tyrA5′ (ACT GCC ATG GTG GCT GAA CTG ACC G (SEQ ID NO: 5)) and tyrA3′ (ACT GGA ATT CTT ATT ATG GGC GGC TGT CAT TG (SEQ ID NO: 6)) and plasmid DNA from vectors pJX1, pJX181, and pJX184 as template DNA. PCR reactions using the Expand™ high fidelity PCR kit from Boehringer Mannheim are performed in a total volume of 50 μl according to the manufacturer's protocol. The tyrA gene is amplified by 30 PCR cycles under the following conditions: 10 min incubation at 95° C., followed by 30 cycles of 1 min at 95° C., 1 min annealing at 56° C. and 1.5 min extension at 72° C. These reactions were followed by a 5 min incubation at 72° C. The PCR product form pJX184 is chosen for gene cloning and digested with NcoI and EcoRI. The gel purified restriction fragment is ligated into NcoI / EcoRI-digested and...

example 2

Cloning of tyrA from Escherichia coli

[0332] The tyrA gene from E. coli is amplified by PCR using primers tyrAecoli5′ (ACT GCC ATG GTT GCT GAA TTG ACC G (SEQ ID NO: 7)) and tyrAecoli3′ (ACT GGA ATT CTT ATT ACT GGC GAT TG (SEQ ID NO:8)) and E. coli DH5a total genomic DNA as template DNA. E. coli total genomic DNA is isolated using the Qiaamp Tissue Kit from Qiagen (Qiagen Inc. Valencia, Calif.). PCR reactions using the Expand high fidelity PCR kit from Boehringer Mannheim are performed in a total volume of 50 μl according to the manufacturer's protocol. The tyrA gene is amplified by 30 PCR cycles under the following conditions: 10 min incubation at 95° C., followed by 30 cycles of 1 min at 95° C., 1 min annealing at 56° C. and 1.5 min extension at 72° C. These reactions are followed by a 5 min incubation at 72° C. The PCR product is digested with NcoI and EcoRI. The gel purified restriction fragment is ligated into NcoI / EcoRI-digested and gel purified pSE280 (Invitrogen Co., Carlsbad...

example 3

Expression of Bifunctional Prephenate Dehydrogenase in E. Coli

[0333] Vectors pMON26588 and pMON26589 are transformed into E. coli DH5α and cells are grown in a 15 ml LB culture to an optical density at 600 nm of about 0.6, and induced by adding IPTG to a final concentration of 0.66 μM. After incubation for 2 to 3 hours, cells are harvested. The cell pellet is resuspended in 0.5 ml 25 mM Tris / HCl, pH8.2 and cells are disrupted by sonication. Membranes and cell debris are sedimented by centrifugation at 100,000×g for three hours. The supernatant is used in enzyme assays as a crude cell extract. Prephenate dehydrogenase activity is measured in a final volume of 1.5 ml containing 1 mM EDTA, 1 mM DTE, 1 mM NAD, and 1 mM prephenate (Ba-salt) in 25 mM Tris / HCl pH 8.2. The specific activity of prephenate dehydrogenase is determined by monitoring the conversion of NAD+ to NADH as described in Methods in Enzymology Vol. 17 (Part A) pages 564-574 (1970). Results are shown in table 1, below. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
weightaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

The present invention is in the field of plant genetics and biochemistry. More specifically, the invention relates to genes associated with the tocopherol biosynthesis pathway. The present invention provides and includes nucleic acid molecules, proteins, and antibodies associated with the genes of the tocopherol biosynthesis pathway. The present invention also provides methods for utilizing such agents, for example in gene isolation, gene analysis and the production of transgenic plants. Moreover, the present invention includes transgenic plants modified to express proteins associated with the tocopherol pathway. In addition, the present invention includes methods for the production of products from the tocopherol biosynthesis pathway.

Description

CROSS-REFERENCE TO RELATED APPLICATION [0001] This application claims the benefit of and priority to U.S. Provisional Application No. 60 / 289,527, filed May 9, 2001, which is herein incorporated by reference in its entirety.FIELD OF THE INVENTION [0002] The present invention is in the field of plant genetics and biochemistry. More specifically, the invention relates to genes associated with the tocopherol biosynthesis pathway. The present invention provides and includes nucleic acid molecules, proteins, and antibodies associated with the genes of the tocopherol biosynthesis pathway. The present invention also provides methods for utilizing such agents, for example in gene isolation, gene analysis and the production of transgenic plants. Moreover, the present invention includes transgenic plants modified to express proteins associated with the tocopherol pathway. In addition, the present invention includes methods for the production of products from the tocopherol biosynthesis pathway...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A01H5/00C11B1/00C12N1/12C12N1/20C12N15/11C12N15/82C12N5/04C12Q1/68A01H1/00C07K14/47C11C3/00C12N1/21C12N9/02C12N9/90C12N15/09C12N15/53C12N15/54
CPCC07K14/47C12N15/8243C12N9/90C12N9/001
Inventor VALENTIN, HENRY E.MITSKY, TIMOTHY A.
Owner MONSANTO TECH LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products